Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) traded down 9% during trading on Wednesday . The stock traded as low as $0.46 and last traded at $0.46. 155,053 shares traded hands during mid-day trading, an increase of 1,971% from the average session volume of 7,488 shares. The stock had previously closed at $0.50.
bioAffinity Technologies Stock Performance
The stock’s 50 day moving average price is $0.44 and its two-hundred day moving average price is $0.83.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
See Also
- Five stocks we like better than bioAffinity Technologies
- Conference Calls and Individual Investors
- Buffett’s on the Sidelines – Should You Follow?
- Find and Profitably Trade Stocks at 52-Week Lows
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
